Sinaptica's neuromodulation therapy slows Alzheimer's brain atrophy

Neuromodulation Slows Alzheimer’s Brain Atrophy

Neuromodulation Slows Alzheimer’s Brain Atrophy Researchers at Sinaptica Therapeutics have found that their new personalized therapy, using rTMS-EEG, which shows promising potential in slowing brain atrophy and enhancing brain connectivity in Alzheimer’s patients. This innovative non-invasive treatment targets the Default Mode Network (DMN), a critical brain area for memory severely affected by Alzheimer’s disease. The […]

Neuromodulation Slows Alzheimer’s Brain Atrophy Read More »